Trend Analysis of Cancer Mortality and Incidence in Panama, Using Joinpoint Regression Analysis

Medicine (United States)

Volumn 94, Issue 24, 2015, Pages

  Politis, Michael ^a   Higuera, Gladys ^b   Chang, Lissette Raquel ^c   Gomez, Beatriz ^a   Bares, Juan ^d   Motta, Jorge ^a  

^a GORGAS MEMORIAL INSTITUTE FOR HEALTH STUDIES   (Panama)

^b Santo Tomas Hospital   (Panama)

^c NSWC Panama City Division   (Panama)

^d FUNDACANCER   (Panama)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AWARENESS; BLADDER CANCER; BODY WEIGHT; BODY WEIGHT CHANGE; BREAST CANCER; BRONCHUS CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM; ECONOMIC ASPECT; FEMALE; HIGH INCOME COUNTRY; HUMAN; LIFESTYLE; LIFESTYLE MODIFICATION; LIVER CANCER; LUNG CANCER; MALE; MIDDLE INCOME GROUP; MORTALITY RATE; NONHUMAN; NUTRITION; OVARY CANCER; PANCREAS CANCER; PHARYNX; PHARYNX CANCER; PROSTATE CANCER; REGRESSION ANALYSIS; RISK FACTOR; SKIN CANCER; STOMACH CANCER; TREND STUDY; UTERINE CERVIX CANCER; WART VIRUS; INCIDENCE; MORTALITY; NEOPLASMS; PANAMA; REGISTER; SEX RATIO; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE;

FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASMS; PANAMA; REGISTRIES; REGRESSION ANALYSIS; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 84941360231     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000970     Document Type: Article

References (65)

1. World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks Geneva, Switzerland: World Health Organization; 2009.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics for Hispanics/ Latinos, 2012. CA Cancer J Clin. 2012;62:283–298.
3. The World Bank. Data: Latin America & Caribbean (developing only). 2013; http://data.worldbank.org/country/panama. (December 9, 2013)
4. Panamerican Health Organization. Health in the Americas: Regional outlook and Country profiles 2012; 91(9):229 p. http://www.paho.org/saludenlasamericas/
5. Ministerio de Salud de Panamá [Panamanian Ministry of Health], Registro Nacional de Cáncer de Panamá [Panamanian National Cancer Registry], 2011. http://190.34.154.93/rncp/
6. Ward EM, Thun MJ, Hannan LM, et al. Interpreting cancer trends. Ann N Y Acad Sci. 2006;1076:29–53.
7. Esteban L, Cleries R, Galvez J, et al. REGSTATTOOLS: Freeware statistical tools for the analysis of disease population databases used in health and social studies. BMC Public Health. 2013;13:201.
8. Bosetti C. Trends in cancer mortality in the Americas, 1970–2000. Ann Oncol. 2005;16:489–511.
9. La Vecchia C, Lucchini F, Negri E, et al. Trends in cancer mortality in the Americas, 1970–2000. Eur J Cancer. 1993;29A:431–470.
10. Piñeros M, Hernandez G, Bray F. Increasing mortality rates of common malignancies in Colombia: an emerging problem. Cancer. 2004;101:2285–2292.
11. Chatenoud L, Bertuccio P, Bosetti C, et al. Trends in mortality from major cancers in the Americas: 1980–2010. Ann Oncol. 2014;25:1843–1853.
12. World Health Organization. International Statistical Classification of Diseases and Relatedhealth Problems. Tenth revision. Geneva, Switzerland: World Health Organization; 1995.
13. Fritz AG. International Classification of Diseases for Oncology: ICD-O. Geneva, Switzerland: World Health Organization; 2000
14. Ahmad OB, Boshi-Pinto C, Lopez AD, et al. Age standardization of rates: A new WHO standard. Geneva, Switzerland: World Health Organization; 2001. http://www.who.int/healthinfo/paper31.pdf.
15. Surveillance Research Program, National Cancer Institute SEER*Stat software (www.seer.cancer.gov/seerstat)version8.1.2.
16. Joinpoint Regression Program, Version 4.0.4. May 2013; Statistical Research and Applications Branch, National Cancer Institute.
17. Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–351.
18. Clark HC. Preliminary notes on neoplasms found in the inhabitants of Panama Canal Zone, with special references to their occurrence in the negro and mestizo. Proc Med Assoc Isthmian CZ. 1915;7:65–85.
19. Tomlinson WJ, Wilson LA. The incidence of malignant tumors in British West Indian and Panamanian Negro Autopsy Populations. Cancer Res. 1945;5:368–371.
20. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917.
21. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
22. Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19:1893–1907.
23. Ferlay JSH, Bray F, Forman D, Mathers C, Parkin DM GLOBOCAN 2008, Cancer incidence and mortality worldwide: No. 10 [Internet]. Lyon (France): IARC CancerBase; 2010. http://globocan.iarc.fr.
24. Perego UA, Lancioni H, Tribaldos M, et al. Decrypting the mitochondrial gene pool of modern Panamanians. PLoS One. 2012;7:e38337.
25. Rebbeck TR, Devesa SS, Chang BL, et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of African descent. Prostate Cancer. 2013;2013:560857.
26. Bock CH, Schwartz AG, Ruterbusch JJ, et al. Results from a prostate cancer admixture mapping study in African-American men. Hum Genet. 2009;126:637–642.
27. Bouchardy C, Fioretta G, Rapiti E, et al. Recent trends in prostate cancer mortality show a continuous decrease in several countries. Int J Can. 2008;123:421–429.
28. Chatenoud L, Bertuccio P, Bosetti C, et al. Trends in cancer mortality in Brazil, 1980–2004. Eur J Cancer Prev. 2010;19:79–86.
29. Niclis C, Pou SA, Bengio RH, et al. Prostate cancer mortality trends in Argentina 1986–2006: an age-period-cohort and joinpoint analysis. Cad Saude Publica. 2011;27:123–130.
30. Piñeros M, Gamboa O, Hernandez-Suarez G, et al. Patterns and trends in cancer mortality in Colombia 1984–2008. Cancer Epidemiol. 2013;37:233–239.
31. Colditz GA, Samplin-Salgado M, Ryan CT, et al. Harvard report on cancer prevention, volume 5: fulfilling the potential for cancer prevention: policy approaches. Cancer Causes Control. 2002;13:199–212.
32. Gonzalez-Robledo MC, Gonzalez-Robledo LM, Nigenda G. Formulacion de politicas públicas sobre el cáncer de mama en América Latina [Public policy-making on breast cancer in Latin America]. Rev Panam Salud Publica. 2013;33:183–189.
33. Autier P, Boniol M, Gavin A, et al. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ. 2011;343:d4411.
34. Siesling S, van Dijck JAAM, Visser O, et al. Trends in incidence and mortality from cancer in The Netherlands in the period 1989–1998. Eur J Cancer. 2003;39:2521–2530.
35. Webb ML, Cady B, Michaelson JS, et al. A failure analysis of invasive breast cancer. Cancer. 2013;120:2839–2846.
36. Youlden DR, Cramb SM, Dunn NA, et al. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36:237–248.
37. Van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152:514–527.
38. Hayes J, Richardson A, Frampton C. Population attributable risks for modifiable lifestyle factors and breast cancer in New Zealand women. Intern Med J. 2013;43:1198–1204.
39. World Health Organization. Report of a Joint WHO/FAO Expert Consultation. Diet Nutrition and the Prevention of Chronic Diseases. WHO Technical Report Series no. 916. Geneva, Switzerland: World Health Organization; 2002.
40. Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes. 2008;32:1431–1437.
41. Sasson M, Lee M, Jan C, et al. Prevalence and associated factors of obesity among Panamanian adults. 1982–2010. PLoS One 2014; 9: e91689.
42. Gandini S, Botteri E, Iodice S, et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer. 2008;122:155–164.
43. Moreno AL, Roa R, McDonald Posso AJ, et al. Encuesta Nacional de Salud y Calidad de Vida. ENSCAVI. Panama, Panama: Instituto Conmemorativo Gorgas de Estudios de la Salud; 2007.
44. Mc Donald A, Motta J, Roa R, et al. Prevalencia de Factores de Riesgo Asociados a Enfermedad Cardiovascular (PREFEC) [Prevalence of Risk Factors Associated to Cardiovascular Disease]. Panama, Panama: Instituto Conmemorativo Gorgas de Estudios de la Salud; 2010.
45. Printz C. American Cancer Society reports progress in reducing cancer deaths: however, some groups still lag behind this trend. Cancer. 2011;117:4573–4574.
46. Harris JE. Cigarette smoking among successive birth cohorts of men and women in the United States during 1900–80. J Natl Cancer Inst. 1983;71:473–479.
47. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249.
48. Bosetti C, Bertuccio P, Malvezzi M, et al. Cancer mortality Europe, 2005–2009, and an overview of trends since 1980. Ann Oncol. 2013;24:2657–2671.
49. Kachuri L, De P, Ellison LF, et al. Cancer incidence, mortality and survival trends in Canada, 1970–2007. Chronic Dis Inj Can. 2013;33:69–80.
50. Boffetta P, La Vecchia C, Levi F, et al. Mortality patterns and trends for lung cancer and other tobacco-related cancers in the Americas, 1955–1989. Int J Epidemiol. 1993;22:377–384.
51. Ballesteros VHH. La demanda de cigarrillos en panamá 2010. http://www.minsa.gob.pa/sites/default/files/publicacion-general/estudio_de_la_demanda_de_tabaco_ciet-panama-abril-2010.pdf.
52. Center MM, Jemal A, Smith RA, et al. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009;59:366–378.
53. Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2009;18:1688–1694.
54. Karsa LV, Lignini TA, Patrick J, et al. The dimensions of the CRC problem. Best Pract Res Clin Gastroenterol. 2010;24:381–396.
55. Bardou M, Barkun AN, Martel M. Republished: obesity and colorectal cancer. Postgrad Med J. 2013;89:519–533.
56. Filozof C, Gonzalez C, Sereday M, et al. Obesity prevalence and trends in Latin-American countries. Obes Rev. 2001;2:99–106.
57. Huxley RR, Ansary-Moghaddam A, Clifton P, et al. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer. 2009;125:171–180.
58. Webber L, Kilpi F, Marsh T, et al. High rates of obesity and noncommunicable diseases predicted across Latin America. PLoS One. 2012;7:e39589.
59. Cuevas A, Alvarez V, Olivos C. The emerging obesity problem in Latin America. Expert Rev Cardiovasc Ther. 2009;7:281–288.
60. Parkin DM. Cancer in developing countries. Cancer Surv. 1994;19–20:519–561.
61. Vidal C, Hoffmeister L, Biagini L. Tendencia de la mortalidad por cancer de cuello uterino en Chile: aplicacion de modelos de regresion joinpoint [Trend in cervical cancer mortality in Chile: application of joinpoint regression models]. Rev Panam Salud Publica. 2013;33:407–413.
62. Zaldívar Y, Mo L, Tribaldos M, et al. Risk factors and prevalence of cervical HPV infection in Panamanian women: A national stratified study. Paper presented at: Papilloma virus Conference & Clinical and Public Health Workshops. 2012 Nov 30–Dec 6; San Juan, Puerto Rico. www.hpv2012pr.org/HPV2012_PUERTO_RICO_Abstracts_Epidemiology
63. Jemal A, Simard EP, Dorell C, et al. Annual Report to the Nation on the Status of Cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013;105:175–201.
64. Brown LM. The role of race/ethnicity in the epidemiology of esophageal cancer. J Assoc Acad Minor Phys. 2000;11:32–37.
65. Wu X, Chen VW, Andrews PA, et al. Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences. Cancer Causes Control. 2007;18:585–593.